Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microbiotix Inc.

www.microbiotix.com

Latest From Microbiotix Inc.

'Slow Money As Bad As No Money' – SMEs Struggle For Superbug Funds

The key to getting funding for small biotechs which focus on tackling antimicrobial resistance is to get private investors interested to top up 'push' incentives from the likes of CARB-X, the AMR Centre's Peter Jackson tells Scrip. 

Infectious Diseases Financing

Brits Lead Charge In Global Battle Against Antimicrobial Resistant Superbugs

During the annual BIO International conference in June, researchers from the UK – which has pushed antimicrobial resistance to front and center on the global stage – discussed ongoing efforts for incentivizing antibiotic discovery and development, and the challenges that remain when it comes to management and resolution of the world’s AMR crisis.

Innovation Research & Development

O'Neill: UK 'Lost Focus' On Antibiotic Crisis And Pharma Must Do More

The time for talking is over when it comes to antimicrobial resistance, says Jim O'Neill, urging the government to 'rediscover the passion for championing' initiatives in the UK, notably the new AMR Centre in Alderley Park near Manchester.

Infectious Diseases Research & Development

UK R&D Centre for Antimicrobial Resistance Goes Into Battle

The UK's recently launched AMR Centre has launched two R&D collaborations and plans two more this year.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Microbiotix Inc.
  • Senior Management
  • Terry L Bowlin, PhD, Pres. & CEO
    Donald T Moir, PhD, CSO
    Richard Gauthier, Head, Bus. Dev.
  • Contact Info
  • Microbiotix Inc.
    Phone: (508) 757-2800
    One Innovation Dr.
    #3 Biotech Bldg
    Worcester, MA 01605
    USA
UsernamePublicRestriction

Register